Keyword Suggestions

Results
 
 
Account Login
 
Username
 
 
 
Password
 
 
 
 
 

Library Navigation

 
 

Browse Conferences

 
 
 
39 Results Found, Showing 1 - 39
Sort By:
View:
Filter By:
Date/Time
Conference
Keyword
My Content
Start Date/Time:
End Date/Time:
 
Go
 
Conference
 
Keywords:
Click here to clear this filter
 
 
Go
Show only the content that I own
 
 
October 17, 2009 - Saturday
 
rating
SA01 - Molecular Characteristics of NSCLC 
Relevancy:
89.14% 
 
Date/Time:
October 17, 2009   8:10am - 8:45am
 
Length:
24m 31s - 36 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
John Minna, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA01 - Molecular Characteristics of NSCLC 
Relevancy:
89.14% 
 
Date/Time:
October 17, 2009   8:10am - 8:45am
 
Length:
24m 31s - 36 Slides  
 
Speaker:
John Minna, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA05 - HspC90 as Emerging Therapy in HER2 + Breast Cancer 
Relevancy:
29.32% 
 
Date/Time:
October 17, 2009   10:45am - 11:20am
 
Length:
17m 21s - 57 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Shanu Modi, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA05 - HspC90 as Emerging Therapy in HER2 + Breast Cancer 
Relevancy:
29.32% 
 
Date/Time:
October 17, 2009   10:45am - 11:20am
 
Length:
17m 21s - 57 Slides  
 
Speaker:
Shanu Modi, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA08 - Using Targeted Agents (EGFR and VEGF Inhibitors) as Radiation Modifiers 
Relevancy:
36.49% 
 
Date/Time:
October 17, 2009   1:35pm - 2:10pm
 
Length:
26m 41s - 36 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
David B. Solit, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA08 - Using Targeted Agents (EGFR and VEGF Inhibitors) as Radiation Modifiers 
Relevancy:
36.49% 
 
Date/Time:
October 17, 2009   1:35pm - 2:10pm
 
Length:
26m 41s - 36 Slides  
 
Speaker:
David B. Solit, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA09 - New Molecular Imaging Agents Provide a Better Look at Cancer 
Relevancy:
37.92% 
 
Date/Time:
October 17, 2009   2:10pm - 2:45pm
 
Length:
25m 15s - 28 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Jerry Collins, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA09 - New Molecular Imaging Agents Provide a Better Look at Cancer 
Relevancy:
37.92% 
 
Date/Time:
October 17, 2009   2:10pm - 2:45pm
 
Length:
25m 15s - 28 Slides  
 
Speaker:
Jerry Collins, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA11 - The Future of Oncology - Drugs in the Pipeline 
Relevancy:
75.37% 
 
Date/Time:
October 17, 2009   3:35pm - 4:10pm
 
Length:
43m 03s - 31 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Bruce A. Chabner, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA11 - The Future of Oncology - Drugs in the Pipeline 
Relevancy:
75.37% 
 
Date/Time:
October 17, 2009   3:35pm - 4:10pm
 
Length:
43m 03s - 31 Slides  
 
Speaker:
Bruce A. Chabner, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 24, 2009 - Thursday
 
rating
ON104 - EBP Update 
Relevancy:
20.49% 
 
Date/Time:
September 24, 2009   2:45pm - 3:15pm
 
Length:
33m 08s - 33 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Dana N. Rutledge, RN, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HN101 - Concomitant Chemoradiotherapy 
Relevancy:
21.42% 
 
Date/Time:
September 24, 2009   3:30pm - 4:00pm
 
Length:
38m 18s - 52 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Ezra EW Cohen, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
A107 - Germ Cell Tumors 
Relevancy:
34.93% 
 
Date/Time:
September 24, 2009   3:40pm - 4:00pm
 
Length:
27m 14s - 58 Slides  
 
Total Credits:
0.25 CME/CE  
 
Speaker:
Craig R. Nichols, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
U106 - New Targets, New Agents, New Trials for Bladder Cancer 
Relevancy:
33.20% 
 
Date/Time:
September 24, 2009   4:05pm - 4:35pm
 
Length:
28m 15s - 52 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Dean F. Bajorin, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
U108 - What is the Standard of Care for Metastatic Renal Cell Carcinoma: First-line, Second-line? 
Relevancy:
25.13% 
 
Date/Time:
September 24, 2009   5:10pm - 5:40pm
 
Length:
21m 35s - 56 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Dean F. Bajorin, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM108 - Therapy-Related Myeloid Neoplasms: The Price of Progress? 
Relevancy:
26.18% 
 
Date/Time:
September 24, 2009   5:10pm - 5:40pm
 
Length:
26m 24s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Wendy Stock, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 25, 2009 - Friday
 
B202 - New Directions in the Treatment of 'Triple Negative' Breast Cancer 
Relevancy:
18.85% 
 
Date/Time:
September 25, 2009   9:25am - 9:55am
 
Length:
31m 46s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Lee S. Schwartzberg, MD, FACP (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM202 - Indolent Lymphomas: Issues in Clinical Practice 
Relevancy:
20.37% 
 
Date/Time:
September 25, 2009   9:25am - 9:55am
 
Length:
28m 35s - 61 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Michael L. Grossbard, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
ON202 - Survivorship Care Plans 
Relevancy:
23.62% 
 
Date/Time:
September 25, 2009   9:25am - 9:55am
 
Length:
30m 24s - 29 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM204 - Challenging Cases in NHL and HL 
Relevancy:
16.10% 
 
Date/Time:
September 25, 2009   2:05pm - 2:35pm
 
Length:
26m 02s - 29 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speakers:
Ranjana H. Advani, MD (Speaker Disclosure)
 
David G. Maloney, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
B206 - Management of Brain Metastases: New Treatment Modalities 
Relevancy:
22.51% 
 
Date/Time:
September 25, 2009   4:05pm - 4:35pm
 
Length:
33m 45s - 57 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Michelle Melisko, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
ON206 - Spirituality - What's New 
Relevancy:
16.85% 
 
Date/Time:
September 25, 2009   4:05pm - 4:35pm
 
Length:
32m 54s - 31 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
 
Format:
     
  Synched Audio / Slides
 

 
September 26, 2009 - Saturday
 
rating
L301 - Multi-modality Treatment Strategies in the Treatment of Curative Lung Cancer 
Relevancy:
58.21% 
 
Date/Time:
September 26, 2009   8:15am - 8:45am
 
Length:
25m 45s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Wayne L. Hofstetter, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SC301 - Vitamin D 
Relevancy:
32.29% 
 
Date/Time:
September 26, 2009   8:15am - 8:45am
 
Length:
47m 47s - 36 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Joan M. Lappe, PhD, RN, FAAN (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L302 - Molecular and Genomic Determinants of Lung Carcinogenesis 
Relevancy:
100.00% 
 
Date/Time:
September 26, 2009   8:50am - 9:20am
 
Length:
29m 09s - 30 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Ignacio I. Wistuba, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
SC302 - What Should I Eat? 
Relevancy:
18.82% 
 
Date/Time:
September 26, 2009   8:50am - 9:20am
 
Length:
17m 30s - 25 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Joan M. Lappe, PhD, RN, FAAN (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L303 - Current Status of the Neoadjuvant and Adjuvant Chemotherapy of Lung Cancer 
Relevancy:
49.96% 
 
Date/Time:
September 26, 2009   9:25am - 9:55am
 
Length:
31m 17s - 48 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Scott Gettinger, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GI303 - Hepatocellular Carcinoma: New Trends and Contemporary Management 
Relevancy:
27.32% 
 
Date/Time:
September 26, 2009   9:25am - 9:55am
 
Length:
35m 09s - 59 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Andrew X. Zhu, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
Plenary301 - Waun Ki Hong's Founding Chair Lectureship 
Relevancy:
21.85% 
 
Date/Time:
September 26, 2009   11:00am - 11:45am
 
Length:
54m 50s - 26 Slides  
 
Total Credits:
0.75 CME/CE  
 
Speaker:
Andrew C. von Eschenbach, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
L304 - Current Status of Targeted Therapies in Lung Cancer 
Relevancy:
53.68% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
38m 36s - 54 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Scott Gettinger, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GI304 - Cytotoxic and Targeted Agents in Gastroesophageal Cancer 
Relevancy:
16.63% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
38m 40s - 62 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Manish P. Shah, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SC304 - Cardiac Complications of Old and New "Targeted" Therapies 
Relevancy:
22.51% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
37m 00s - 36 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Anju Nohria, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L305 - What is New in Radiotherapy and the Management of NSCLC? 
Relevancy:
66.07% 
 
Date/Time:
September 26, 2009   2:05pm - 2:35pm
 
Length:
21m 49s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Quynh-Thu Le, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM305 - Debate: Is Allogenic Stem Cell Transplant in First Remission the Optimal Therapy for All Adults with ALL? 
Relevancy:
20.34% 
 
Date/Time:
September 26, 2009   2:05pm - 3:10pm
 
Length:
46m 53s - 78 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speakers:
Jerald P. Radich, MD (Speaker Disclosure)
 
Wendy Stock, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
SC305 - Overview of New Developments in Patient Communication 
Relevancy:
33.24% 
 
Date/Time:
September 26, 2009   2:05pm - 2:35pm
 
Length:
28m 52s - 37 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Thomas Smith (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L306 - Management of Limited and Extensive Small-Cell Lung Cancer 
Relevancy:
71.98% 
 
Date/Time:
September 26, 2009   2:40pm - 3:10pm
 
Length:
25m 58s - 53 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Ronald B. Natale, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L307 - Current Status in the Management of Stage IV NSCLC 
Relevancy:
61.66% 
 
Date/Time:
September 26, 2009   4:05pm - 4:35pm
 
Length:
42m 26s - 75 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Ronald B. Natale, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GI307 - Adjuvant and Neoadjuvant Approaches for Localized Pancreatic Cancer 
Relevancy:
17.83% 
 
Date/Time:
September 26, 2009   4:05pm - 4:35pm
 
Length:
56m 59s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Douglas B. Evans, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L308 - Personalized Targeted Therapy in Lung Cancer 
Relevancy:
53.39% 
 
Date/Time:
September 26, 2009   4:40pm - 5:10pm
 
Length:
55m 05s - 55 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Waun Ki Hong, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
39 Results Found, Showing 1 - 39